Nano X Imaging Ltd
NNOX
Market Cap$371.48M
Close$
$-5.28
200.9% downside
Current Fair Value
200.9% downsideOvervalued by 200.9% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $371.48 Million |
|---|---|
| Enterprise Value | $338.61 Million |
| Dividend Yield | $0 (0%) |
| Earnings per Share | $-1.08 |
| Beta | 1.99 |
| Outstanding Shares | 58,005,000 |
Return
| Return on Equity | - |
|---|---|
| Return on Assets | - |
| Return on Invested Capital | - |
Valuation & Multiples
| P/E Ratio | -6.41 |
|---|---|
| PEG | -78.62 |
| Price to Sales | - |
| Price to Book Ratio | 1.74 |
| Enterprise Value to Revenue | 29.33 |
| Enterprise Value to EBIT | -5.88 |
| Enterprise Value to Net Income | -7 |
| Total Debt to Enterprise | 0.02 |
| Debt to Equity | 0.04 |
Revenue Sources
No data
Insider Trades
ESG Score
No data
About Nano X Imaging Ltd
40 employeesNano-X Imaging Ltd operates as a medical imaging technology company. The Company offers cloud-based image analysis, online diagnosis, and billing services. Nano-X Imaging serves governments, hospitals, and clinic chains in Israel.